Erythrocyte and Platelet Phospholipid Fatty Acids as Markers of Advanced Non-Small Cell Lung Cancer: Comparison with Serum Levels of Sialic Acid, TPS and Cyfra 21-1

Author： de Castro Javier   Rodriguez Marina   Martinez-Zorzano Vicenta   Hernandez-Hernandez Angel   Llanillo Marcial   Sanchez-Yague Jesus  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.26, Iss.4, 2008-05, pp. : 407-418

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Elevated serum levels of TPS and CYFRA 21-1 predict poor prognosis in advanced non-small-cell lung cancer patients treated with gefitinib

By Chen Fengsheng   Luo Xi   Zhang Jinbiao   Lu Yang   Luo Rongcheng  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 950-957

Humana Press, Inc

Access to resources Recommend Favorite

Comparison of Changes in Erythrocyte and Platelet Fatty Acid Composition and Protein Oxidation in Advanced Non-Small Cell Lung Cancer

By de Castro Javier   Hernández-Hernández Angel   Rodríguez Marina   Llanillo Marcial   Sánchez-Yagüe Jesús  

Cancer Investigation, Vol. 24, Iss. 4, 2006-07 ,pp. : 339-345

Informa Healthcare

Access to resources Recommend Favorite

Declines in serum CYFRA21-1 and carcinoembryonic antigen as predictors of chemotherapy response and survival in patients with advanced non-small cell lung cancer

By          

Experimental and Therapeutic Medicine, Vol. 4, Iss. 2, 2012-01 ,pp. : 243-248

Spandidos Publications

Access to resources Recommend Favorite

Decreased levels of serum cytokeratin 19 fragment CYFRA 211 predict objective response to chemotherapy in patients with non-small cell lung cancer

By        

Experimental and Therapeutic Medicine, Vol. 6, Iss. 2, 2013-01 ,pp. : 355-360

Spandidos Publications

Access to resources Recommend Favorite

Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib

By                      

Experimental and Therapeutic Medicine, Vol. 2, Iss. 4, 2011-01 ,pp. : 685-693

Spandidos Publications

Access to resources Recommend Favorite